RecruitingPhase 3NCT05287321

The Efficacy of Aspirin Combined With Hydroxychloroquine Treatment in High Risk Pregnancies for Preeclampsia

The Efficacy of Aspirin Combined With Hydroxychloroquine Treatment in High Risk Pregnancies for Preeclampsia: a Multicenter, Open-label, Single Arm Trial, Investigator Initiated Study


Sponsor

Yoo-min Kim

Enrollment

58 participants

Start Date

May 31, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This study is prospective, single arm group ,open label, and multicenter trial (with two parallel-group \[Hydroxychloroquine 200mg with Aspirin 100mg or Aspirin 100mg\])


Eligibility

Sex: FEMALEMin Age: 19 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether combining aspirin with hydroxychloroquine (a drug used for lupus and malaria) can help prevent preeclampsia — a dangerous pregnancy condition involving high blood pressure and organ damage — in women who are at high risk because of their previous pregnancy complications. **You may be eligible if...** - You are a pregnant woman aged 19–50 carrying a single baby - You have at least one prior pregnancy complicated by preeclampsia, fetal growth restriction, or unexplained baby loss (intrauterine fetal death) - You have provided informed consent to participate **You may NOT be eligible if...** - You have been in another interventional clinical trial in the past 3 months - Your baby has been diagnosed with a major abnormality at the 11–13 week scan - You have significant kidney or liver problems - You have a bleeding disorder, peptic ulcer, or allergy to aspirin - You have an allergy to hydroxychloroquine, or known eye disease (hydroxychloroquine can affect vision) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGHydroxychloroquine

Hydroxychloroquine 200mg with Aspirin 100mg


Locations(1)

Chung-Ang University Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05287321


Related Trials